RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
RPTP was delisted on the 24th of October, 2016.
81 hedge funds and large institutions have $364M invested in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 15 closing their positions.
26% more capital invested
Capital invested by funds: $289M → $364M (+$75M)
4% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 26
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
1% less funds holding
Funds holding: 82 → 81 (-1)
71% less call options, than puts
Call options by funds: $6.95M | Put options by funds: $24.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$19M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$7.02M |
| 3 |
State Street
Boston,
Massachusetts
|
+$5.85M |
| 4 |
Goldman Sachs
New York
|
+$5.32M |
| 5 |
Millennium Management
New York
|
+$3.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$4.11M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.01M |
| 3 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$3.12M |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$2.04M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$1.16M |
RPTP Hedge Fund Activity: Q4 2014 in Review
81 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) for Q4 2014, worth a combined $364M — up 26% from $289M a quarter earlier.
Fund positioning in RPTP was balanced in Q4 2014: 15 funds opened new positions, 15 closed out, 27 added to existing stakes and 26 trimmed.
The largest buyer was Oracle Investment Management, opening a new position worth an estimated $19M. The largest seller was Nomura Holdings, exiting entirely with an estimated $4.11M sold.
- 81 institutional investors held RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) as of Q4 2014, down from 82 in Q3 2014.
- Funds reported $364M of RAPTOR PHARMACEUTICAL CORP COM STK (DE) stock for Q4 2014, up 26% quarter-over-quarter.
- 15 funds opened new RAPTOR PHARMACEUTICAL CORP COM STK (DE) positions in Q4 2014 and 15 closed out, a net change of 0 holders.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) buyer in Q4 2014 was Oracle Investment Management, an estimated $19M added.
- The largest RAPTOR PHARMACEUTICAL CORP COM STK (DE) seller in Q4 2014 was Nomura Holdings, an estimated $4.11M sold.
Based on aggregated 13F filings for Q4 2014.